PLCE
Children's Place, Inc.
stock NASDAQ

WHAT ARE THE BIGGEST LOSERS ?
* **Biotech/Clinical Catalysts** — REPL, LPCN, ONCO: Small biotechs are highly event-driven. A single disappointing trial result, FDA update, or missed endpoint can cause 20–60%+ drops in one day due to binary risk.
* **Low-Float Micro-Caps** — WORX, ONCO: These have tiny share floats and low trading volume. A few large sells can trigger cascading drops, stop-loss hunting, or panic selling.
|Rank|Ticker & Company|Approx. % Decline|Market Cap (Approx.)|Sector|Why It's Losing Today|
|:-|:-|:-|:-|:-|:-|
|1|**REPL**Replimune Group|\-64%|\~$140M|Biotech (Oncology)|Likely clinical trial disappointment, negative data readout, or safety concerns — common trigger for sharp biotech drops.|
|2|**WORX**SCWorx Corp.|\-31%|\~$1M|Healthcare Tech|Extremely low-float micro-cap; prone to heavy selling on thin volume or profit-taking after any prior run.|
|3|**PLCE**Children's Place|\-28%|\~$63M|Retail (Children's Apparel)|Weak earnings, poor guidance, or broader retail sector pressure (consumer spending concerns).|
|4|**AFJK** Aimei Health Technology|\-28%|\~$247M|Health Tech|Possible negative news, dilution, or sector rotation away from smaller health plays.|
|5|**ONCO**Onconetix|\-27%|Micro (\~$0.5M)|Biotech|High-volatility micro-cap; often reacts to trial updates, regulatory issues, or low-volume selloffs.|

WHAT ARE THE BIGGEST LOSERS ?
* **Biotech/Clinical Catalysts** — REPL, LPCN, ONCO: Small biotechs are highly event-driven. A single disappointing trial result, FDA update, or missed endpoint can cause 20–60%+ drops in one day due to binary risk.
* **Low-Float Micro-Caps** — WORX, ONCO: These have tiny share floats and low trading volume. A few large sells can trigger cascading drops, stop-loss hunting, or panic selling.
|Rank|Ticker & Company|Approx. % Decline|Market Cap (Approx.)|Sector|Why It's Losing Today|
|:-|:-|:-|:-|:-|:-|
|1|**REPL**Replimune Group|\-64%|\~$140M|Biotech (Oncology)|Likely clinical trial disappointment, negative data readout, or safety concerns — common trigger for sharp biotech drops.|
|2|**WORX**SCWorx Corp.|\-31%|\~$1M|Healthcare Tech|Extremely low-float micro-cap; prone to heavy selling on thin volume or profit-taking after any prior run.|
|3|**PLCE**Children's Place|\-28%|\~$63M|Retail (Children's Apparel)|Weak earnings, poor guidance, or broader retail sector pressure (consumer spending concerns).|
|4|**AFJK** Aimei Health Technology|\-28%|\~$247M|Health Tech|Possible negative news, dilution, or sector rotation away from smaller health plays.|
|5|**ONCO**Onconetix|\-27%|Micro (\~$0.5M)|Biotech|High-volatility micro-cap; often reacts to trial updates, regulatory issues, or low-volume selloffs.|